shim
shim signature
shim


   LUCRIN DEPOT 3.75MG

   LUCRIN DEPOT 11.25MG




















 







.
LUCRIN DEPOT 3.75MG

Ingredient(s):
Lucrin Depot. each vial contains:
Leuprorelin acetate .......................3.75mg
Gelatin .......................0.65mg
Mannitol .......................6.6mg

Diluent. each ampoule contains:
Carboxymethylcellulose Sodium ... 10.0mg
Mannitol ............................ 100mg
Polysorbate 80 ............................ 2.0mg
Sterile Water for Injection qs to 2.0ml
Indications :

Prostate Cancer
Leuprolide Acetate for Depot Suspension (3.75 mg) is indicated in the palliative treatment of advanced prostatic cancer.

Endometriosis
Leuprolide Acetate for Depot Suspension 3.75 mg is indicated in the treatment of endometriosis for a period of six months. It can be used as sole therapy or as an adjunct to surgery.

Uterine Fibroids
Leuprolide Acetate for Depot Suspension 3.75 mg is also indicated in the treatment of leiomyoma uteri (uterine fibroids) for a period up to six months.

Breast Cancer
Leuprolide Acetate for Depot Suspension 3.75 mg is indicated for the treatment of breast cancer in pre- and peri-menopausal women in whom hormone therapy is specified.

Precocious Puberty
Leuprolide Acetate for Depot Suspension 3.75 mg is indicated in the treatment of children with Central Precocious Puberty (CPP)

Pack Size :     1 vial in carton
Top of Page

 







.
LUCRIN DEPOT 11.25MG

Ingredient(s):
Lucrin Depot. each vial contains:
Leuprorelin acetate .......................11.25mg
Mannitol ..........................19.45mg
Polymer (Polylactic acid) Abbott Specs......99.30mg

Diluent. each ampoule contains:
Carboxymethylcellulose Sodium ....................... 10.0mg
Mannitol ....................... 100mg
Polysorbate 80 ....................... 2.0mg
Sterile Water for Injection qs to 2.0ml
Indications :

Prostate Cancer
Leuprolide Acetate for Depot Suspension - 3 Month 11.25 mg is indicated in the palliative treatment of advanced prostatic cancer.

Endometriosis
Leuprolide Acetate for Depot Suspension - 3 Month 11.25 mg is indicated in the treatment of endometriosis for a period of six months. It can be used as sole therapy or as an adjunct to surgery.

Uterine Fibroids
Leuprolide Acetate for Depot Suspension - 3 Month 11.25 mg is also indicated in the treatment of leiomyoma uteri (uterine fibroids) for a period up to six months.

Breast Cancer
Leuprolide Acetate for Depot Suspension 11.25 mg is indicated for the treatment of breast cancer in pre- and peri-menopausal women in whom hormone therapy is specified.

Pack Size :     1 vial in carton
Top of Page






shim
shim
shim Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott Laboratories, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott Laboratories, except to identify the product or services of the company.